Yinu Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Low Density Lipoprotein

Cancer Stem Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Molecular cancer therapeutics

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Yinu Wang, Andrea E Calvert, Horacio Cardenas, Jonathon S Rink, Dominik Nahotko, Wenan Qiang, C Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji-Xin Cheng, C Shad Thaxton, Daniela E Matei
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (13) (2024)
Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yinu Wang, Andrea E Calvert, Horacio Cardenas, Jonathon S Rink, Dominik Nahotko, Wenan Qiang, C Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji-Xin Cheng, C Shad Thaxton, Daniela E Matei
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (13) (2024)
Yinu Wang, Andrea E Calvert, Horacio Cardenas, Jonathon S Rink, Dominik Nahotko, Wenan Qiang, C Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji-Xin Cheng, C Shad Thaxton, Daniela E Matei
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (13) (2024)
Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Yinu Wang, Andrea E Calvert, Horacio Cardenas, Jonathon S Rink, Dominik Nahotko, Wenan Qiang, C Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji-Xin Cheng, C Shad Thaxton, Daniela E Matei
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward J Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu Dessai, Ji-Xin Cheng, Daniela E Matei
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum through Nicotinamide N-methyltransferase. Molecular cancer therapeutics (2023)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase. Molecular cancer therapeutics 22 (3) (2023)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase. Molecular cancer therapeutics 22 (3) (2023)
Hao Huang, Guangyuan Zhao, Horacio Cardenas, Andres Felipe Valdivia, Yinu Wang, Daniela E Matei
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase. Molecular cancer therapeutics 22 (3) (2023)
Yaqi Zhang, Yinu Wang, Andres Felipe Valdivia, Hao Huang, Daniela E Matei
DOT1L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling. Molecular cancer research : MCR (2022)